Based on the Quanterix Corp stock forecast from 3 analysts, the average analyst target price for Quanterix Corp is USD 17.83 over the next 12 months. Quanterix Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Quanterix Corp is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Quanterix Corp’s stock price was USD 5.94. Quanterix Corp’s stock price has changed by -9.45% over the past week, -20.69% over the past month and -72.35% over the last year.
No recent analyst target price found for Quanterix Corp
No recent average analyst rating found for Quanterix Corp
Company Overview Quanterix Corp
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts. Read Less
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The com...Read More
Frequently Asked Questions About Quanterix Corp (QTRX) Stock
Based on ratings from 3 analysts Quanterix Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on QTRX's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for QTRX is USD 17.83 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 10.
Unfortunately we do not have enough data on QTRX's stock to indicate if its overvalued.
The last closing price of QTRX's stock was USD 5.94.
The most recent market capitalization for QTRX is USD 0.48B.
Based on targets from 3 analysts, the average taret price for QTRX is projected at USD 17.83 over the next 12 months.
This means that QTRX's stock price may go up by +200.22% over the next 12 months.
We can't find any ETFs which contains Quanterix Corp's stock.
As per our most recent records Quanterix Corp has 441 Employees.
Quanterix Corp's registered address is Building 1, Billerica, MA, United States, 01821.
You can get more information about it from Quanterix Corp's website at https://www.quanterix.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Quanterix Corp (QTRX) Stock
Based on ratings from 3 analysts Quanterix Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on QTRX's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for QTRX is USD 17.83 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 10.
Unfortunately we do not have enough data on QTRX's stock to indicate if its overvalued.
The last closing price of QTRX's stock was USD 5.94.
The most recent market capitalization for QTRX is USD 0.48B.
Based on targets from 3 analysts, the average taret price for QTRX is projected at USD 17.83 over the next 12 months.
This means that QTRX's stock price may go up by +200.22% over the next 12 months.
We can't find any ETFs which contains Quanterix Corp's stock.
As per our most recent records Quanterix Corp has 441 Employees.
Quanterix Corp's registered address is Building 1, Billerica, MA, United States, 01821.
You can get more information about it from Quanterix Corp's website at https://www.quanterix.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for QTRX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
